The Nevada Legislature has asked a federal judge to allow it to intervene in a lawsuit that challenges the state’s insulin transparency law it passed in 2017.
The Pharmaceutical Research and Manufacturers of America or PhRMA filed the lawsuit and argues that the law creates an “effective cap” on insulin prices in violation of the U.S. Constitution.
The law, which is the first of its kind in the nation, mandates transparency from drug companies about the price of their products.
The Nevada Independent reports legislative attorneys filed a motion in federal court yesterday at the direction of Assembly Speaker Jason Frierson.
The motion argues that it has a right to defend itself in creating laws for public health, safety, and welfare of Nevada residents.
